Search

Your search keyword '"Antje Havemeyer"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Antje Havemeyer" Remove constraint Author: "Antje Havemeyer"
27 results on '"Antje Havemeyer"'

Search Results

1. The N-reductive system composed of mitochondrial amidoxime reducing component (mARC), cytochrome b5 (CYB5B) and cytochrome b5 reductase (CYB5R) is regulated by fasting and high fat diet in mice.

2. Discovery of N-(4-Aminobutyl)-N'-(2-methoxyethyl)guanidine as the First Selective, Nonamino Acid, Catalytic Site Inhibitor of Human Dimethylarginine Dimethylaminohydrolase-1 (hDDAH-1)

Catalog

Books, media, physical & digital resources

3. Mitochondrial amidoxime-reducing component 2 (MARC2) has a significant role in N-reductive activity and energy metabolism

4. The Involvement of the Mitochondrial Amidoxime Reducing Component (mARC) in the Reductive Metabolism of Hydroxamic Acids

5. Detoxification of Trimethylamine N-Oxide by the Mitochondrial Amidoxime Reducing Component mARC

6. Human mitochondrial amidoxime reducing component (mARC): An electrochemical method for identifying new substrates and inhibitors

7. Discovery of

8. Defining the Role of the NADH-Cytochrome-b5 Reductase 3 in the Mitochondrial Amidoxime Reducing Component Enzyme System

9. Mitochondrial amidoxime-reducing component 2 (MARC2) has a significant role in

10. T4 lysozyme-facilitated crystallization of the human molybdenum cofactor-dependent enzyme mARC

11. The Pivotal Role of the Mitochondrial Amidoxime Reducing Component 2 in Protecting Human Cells against Apoptotic Effects of the Base Analog N6-Hydroxylaminopurine

12. Electrochemical and mARC-Catalyzed Enzymatic Reduction ofpara-Substituted Benzamidoximes: Consequences for the Prodrug Concept 'Amidoximes instead of Amidines'

13. Functional Characterization of Protein Variants Encoded by Nonsynonymous Single Nucleotide Polymorphisms inMARC1andMARC2in Healthy Caucasians

14. The Involvement of Mitochondrial Amidoxime Reducing Components 1 and 2 and Mitochondrial Cytochrome b5 in N-Reductive Metabolism in Human Cells

15. Dimethylarginine-Dimethylaminohydrolase-2 (DDAH-2) Does Not Metabolize Methylarginines

16. The fourth mammalian molybdenum enzyme mARC: current state of research

17. Reduction of Nω-hydroxy-<scp>L</scp>-arginine by the mitochondrial amidoxime reducing component (mARC)

18. Reduction ofN-Hydroxy-sulfonamides, IncludingN-Hydroxy-valdecoxib, by the Molybdenum-Containing Enzyme mARC

19. HEPATIC, EXTRAHEPATIC, MICROSOMAL, AND MITOCHONDRIAL ACTIVATION OF THEN-HYDROXYLATED PRODRUGS BENZAMIDOXIME, GUANOXABENZ, AND RO 48-3656 ([[1-[(2S)-2-[[4-[(HYDROXYAMINO)IMINOMETHYL]BENZOYL]AMINO]-1-OXOPROPYL]-4-PIPERIDINYL]OXY]-ACETIC ACID)

20. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes

21. Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC)

22. The mammalian molybdenum enzymes of mARC

23. The mitochondrial amidoxime reducing component (mARC): involvement in metabolic reduction of N-oxides, oximes and N-hydroxyamidinohydrazones

24. Activation of the anti-cancer agent upamostat by the mARC enzyme system

25. The mitochondrial Amidoxime Reducing Component (mARC) is involved in detoxification of N-hydroxylated base analogues

26. Biochemical and spectroscopic characterization of the human mitochondrial amidoxime reducing components hmARC-1 and hmARC-2 suggests the existence of a new molybdenum enzyme family in eukaryotes

27. Reduction of Nω-hydroxy-L-arginine by the mitochondrial amidoxime reducing component (mARC).